大名城(600094.SH):擬申請非公開發行不超30億元公司債券
格隆匯2月10日丨大名城(600094.SH)公佈,公司第八屆董事局第二十七次會議決議,審議通過《關於公司符合非公開發行公司債券條件的議案》及逐項審議通過《關於公司非公開發行公司債券方案的議案》。
票面金額為人民幣100元,申請發行總規模不超過人民幣30億元(含30億元),以一次或多次或多期的形式向專業投資者非公開發行。
非公開發行債券為固定利率債券,期限不超過五年(含五年),可以為單一期限品種,也可以為多種期限的混合品種。
此次公司債券所募集資金在扣除發行費用後,全部用於償還公司各類債務、項目建設、補充流動資金或其他符合法律、法規規定及監管機構認可的用途。具體募集資金用途提請股東大會授權董事局或董事局授權人士,根據公司資金需求情況確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.